Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
The Oncologist|May 27, 2004
Preclinical pharmacology of the taxanes: implications of the differencesJoseph Gligorov, Jean Pierre LotzBreast Cancer Research and Treatment|December 23, 2008
Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancerJoseph Gligorov, Jean-Pierre LotzBulletin Du Cancer|October 24, 2020
[Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers]Christophe Maritaz, Laure Napoly, Sylvie Burnel, et al.Bulletin Du Cancer|May 19, 2005
[Cardiac prevention: the oncologic point of view]Joseph Gligorov, Philippe Debourdeau, Oliver Arsovski, et al.Urology Case Reports|September 13, 2016
Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer PatientDaniele G Soares, Françoise Millot, Isabelle Lacroix, et al.Bulletin Du Cancer|September 20, 2016
[High-dose chemotherapy as a strategy to overcome drug resistance in solid tumors]Frédéric Selle, Joseph Gligorov, Daniele G Soares, et al.Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
High-dose chemotherapy for breast cancer: the French PEGASE experienceHenri Roche, Patrice Viens, Pierre Biron, et al.Bulletin Du Cancer|February 20, 2016
[Care pathways of cancer patients: Modeling and risks analysis induced by oral anticancer drugs]Sophie Renet, Christophe Maritaz, Jean-Pierre Lotz, et al.Journal of Clinical Medicine|March 10, 2022
Advance Directives in Oncology and Haematology: A Long Way to Go-A Narrative ReviewKevin Serey, Amélie Cambriel, Adrien Pollina-Bachellerie, et al.Pageof 9